688513.SS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 06:29):

Stats
Dzisiejszy wolumen	350 481
Średni wolumen	457 115
Kapitalizacja rynkowa	7.29B
EPS	CNY0.510 ( 2023-10-26 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	29.90
ATR14	CNY0.113 (0.19%)

Wolumen Korelacja

Długi: 0.09 (neutral)

Krótki: 0.57 (weak)

Signal:(44.481) Neutral

Chengdu Easton Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Chengdu Easton Korelacja - Waluta/Towar

-0.06
( neutral )

-0.17
( neutral )

-0.41
( neutral )

0.09
( neutral )

0.25
( neutral )

Chengdu Easton Finanse

Annual	2023
Przychody:	CNY1.12B
Zysk brutto:	CNY893.36M (80.00 %)
EPS:	CNY1.880

FY	2023
Przychody:	CNY1.12B
Zysk brutto:	CNY893.36M (80.00 %)
EPS:	CNY1.880

FY	2023
Przychody:	CNY0
Zysk brutto:	CNY0 (0.00 %)
EPS:	CNY0

FY	2022
Przychody:	CNY1.17B
Zysk brutto:	CNY974.51M (83.25 %)
EPS:	CNY2.05

Financial Reports:

No articles found.

Chengdu Easton

Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry , and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.